US EditionPublished • loading... • Updated
Patients sought in first-in-human trial of pancreatic cancer treatment
Summary by rarecancernews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Patients sought in first-in-human trial of pancreatic cancer treatment
A first-in-human clinical trial testing RMC-5127, an experimental treatment for people with pancreatic cancer and other cancers marked by a specific genetic mutation called RAS G12V, is now recruiting participants in the U.S. The Phase 1 trial (NCT07349537) is open to adults with pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, as well as those with other types of solid tumors. To be eligible, the individuals’ …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
